Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-23-003052

Chief Operating Officer sold 3,125 shares at an average $8.55 ($26,733)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ADAMS R MARK Chief Operating Officer 2023-01-09 Sale −995 $8.50 $8,458 115,648 D: show line 1 in the form
ADAMS R MARK Chief Operating Officer 2023-01-10 Sale −2,130 $8.58 $18,275 113,518 D: show line 2 in the form
Open-market sales · 3,125 sh · avg $8.55 · $26,733
Loading xslF345X03/doc4.xml…